Table 3.
Subcategory | Number of Cases | Volume Rank | Overall Financial Impact | Cost Rank | Confusion Rate Rank | Weighted Total | Weighted Total Rank |
---|---|---|---|---|---|---|---|
Complications | 672,594 | 5 | $257,099,062 | 5 | 3 | 4.034 | 1 |
Congestive heart failure | 2,320,629 | 2 | $100,475,422 | 8 | 4 | 4.1 | 2 |
Excisional debridement | 100,646 | 12 | $576,461,896 | 4 | 1 | 5.175 | 3 |
Sepsis/bacteremia | 512,632 | 8 | $29,235,465 | 10 | 2 | 5.48 | 4 |
Diabetes mellitus | 3,271,828 | 1 | $33,252,579 | 9 | 8 | 5.893 | 5 |
COPD | 632,026 | 6 | $179,653,514 | 6 | 6 | 6 | 6 |
Respiratory failure | 538,248 | 7 | $948,974,508 | 3 | 7 | 6.244 | 7 |
Renal insufficiency versus failure | 1,924,071 | 4 | $1,898,106,569 | 1 | 10 | 6.331 | 8 |
Chronic kidney disease | 1,981,013 | 3 | $1,657,965,276 | 2 | 12 | 7.158 | 9 |
Epilepsy and seizures | 478,038 | 9 | $8,916,045 | 12 | 5 | 7.635 | 10 |
SIRS with cellulitis | 299,454 | 10 | $13,729,966 | 11 | 9 | 9.706 | 11 |
Arterial embolization | 127,026 | 11 | $138,279,695 | 7 | 11 | 10.244 | 12 |
Malignant ascites | 0 | 13 | $0 | 13 | 13 | 13 | 13 |
Note: COPD: chronic obstructive pulmonary disease; SIRS: systemic inflammatory response syndrome.